Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Viemed HealthcareVMD -0.15%89 14-Day RSI is 25.67 as of Aug. 06, 2026. GuruFocus rates VMD with a GF Score™ of 89/100 and a GF Value™ of $10.95 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Viemed Healthcare ranks better than 97% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Viemed Healthcare 14-Day RSI Related Terms
VMD vs OFIX, VREX, SI: 14-Day RSI Comparison
For the Medical Devices subindustry, Viemed Healthcare's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viemed Healthcare 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Viemed Healthcare's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Viemed Healthcare's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viemed Healthcare (VMD) has a 14-Day RSI of 25.67 as of Aug. 06, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Viemed Healthcare and its competitors. According to the industry distribution chart, Viemed Healthcare ranks #26 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 3%.
Is Viemed Healthcare's 14-Day RSI too high?
Viemed Healthcare's current 14-Day RSI is 25.67. The Medical Devices & Instruments industry median 14-Day RSI is 50.49. Viemed Healthcare's value of 25.67 is 49.2% below this industry median. Based on the distribution chart, Viemed Healthcare ranks #26 out of 866 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Viemed Healthcare has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Viemed Healthcare's 14-Day RSI compare to OFIX and VREX?
According to the Medical Devices & Instruments industry distribution chart, Viemed Healthcare ranks #26 out of 866 companies for 14-Day RSI. This places Viemed Healthcare in the top 3% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 50.49. Viemed Healthcare's value of 25.67 is 49.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 50.49, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viemed Healthcare's current 14-Day RSI of 25.67 is 49.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Viemed Healthcare and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 50.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viemed Healthcare's current 14-Day RSI is 25.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viemed Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Viemed Healthcare (VMD) is currently considered Modestly Undervalued. The stock's GF Value™ is $10.95, compared to a current price of $9.81 — trading 10.5% below its estimated fair value. The current 14-Day RSI is 25.67 and 49.2% below the Medical Devices & Instruments industry median of 50.49. Viemed Healthcare's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Viemed Healthcare (VMD), the current 14-Day RSI is 25.67 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viemed Healthcare (VMD) Overvalued in 2026?
Based on GuruFocus' analysis, Viemed Healthcare stock appears to be undervalued.
The current stock price of $9.81 is trading 10.5% below its estimated GF Value™ of $10.95.
GuruFocus considers Viemed Healthcare to be Modestly Undervalued.
Key valuation signals for VMD:
14-Day RSI: 25.67
GF Value™: $10.95 vs. price of $9.81 (10.5% below fair value)
Industry Position: 49.2% below the Medical Devices & Instruments median (#26 of 866)
No single metric tells the full story. See the VMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
89GF Score
Get the complete analysis for VMD
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VMD has been successfully added to your 
